Immune system functional pathway analysis using single cell network profiling (SCNP): a novel tool in cancer

Alessandra Cesano1, David Spellmeyer

  • 1Nodality, Inc., South San Francisco, CA, USA.

Insights

Novel biomarkers are crucial for cancer immunotherapy response. Single cell network profiling (SCNP) measures immune cell function, providing a systems-level view to identify responsive patients.

Area of Science:

  • Immunology
  • Biomarker Discovery
  • Cancer Research

Background:

  • Cancer immunotherapies have limited success, necessitating new biomarkers.
  • A systems-level approach is needed to understand complex immune responses.
  • Identifying patients likely to respond to immunotherapy remains a challenge.

Purpose of the Study:

  • To introduce Single Cell Network Profiling (SCNP) as a novel method for immune function assessment.
  • To detail the SCNP assay for measuring immune response at a systems level.
  • To demonstrate the utility of SCNP for immune monitoring in cancer therapy.

Main Methods:

  • SCNP is a multiparametric flow cytometry assay.
  • It simultaneously measures extracellular markers and intracellular signaling proteins.
  • Functional capacity is assessed by measuring signaling changes after external modulation.

Main Results:

  • SCNP provides a systems-level assessment of immune function and dysfunction.
  • Simultaneous analysis reveals connectivity within cell signaling networks and immune cell subtypes.
  • The assay involves pre-analytical preparation, modulation, staining, data acquisition, and analysis.

Conclusions:

  • SCNP offers a comprehensive method for immune monitoring.
  • This approach can identify patients likely to benefit from cancer immunotherapies.
  • Understanding immune network connectivity is key for therapeutic advancements.